Volume 32, Number 3—March 2026
Research
Tuberculosis before and during COVID-19 Pandemic, United States, 2010–2023
Table 7
Number of observed and predicted tuberculosis cases reported to the National TB Surveillance System, by origin of birth, United States, 2020–2023*
| Year | All |
US-born |
Non–US-born |
|||||
|---|---|---|---|---|---|---|---|---|
| No. observed | No. predicted | No. observed | No. predicted | No. observed | No. predicted | |||
| 2020 | 7,170 | 8,822 | 2,009 | 2,384 | 5,151 | 6,273 | ||
| 2021 | 7,866 | 8,703 | 2,170 | 2,278 | 5,676 | 6,168 | ||
| 2022 | 8,332 | 8,578 | 2,127 | 2,178 | 6,195 | 6,144 | ||
| 2023 | 9,633 | 8,464 | 2,293 | 2,078 | 7,319 | 6,268 | ||
| Total | 33,001 | 34,567 | 8,599 | 8,918 | 24,341 | 24,852 | ||
*Predicted (counterfactual) frequencies estimated from Poisson models of NTSS data with predictors representing the year the case was counted, the previous year’s TB case count, and an offset representing the size of the US population from the US Census Bureau. Persons born in the United States, certain US territories, or elsewhere to >1 US citizen parent are categorized as US-born. All other persons are categorized as non–US-born. Persons with unknown origin of birth were excluded from the stratified analysis.
Page created: March 04, 2026
Page updated: March 20, 2026
Page reviewed: March 20, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.